BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18686839)

  • 1. The seroprevalence of cytomegalovirus antibodies among prospective blood donors in Jos.
    Alao OO; Joseph DE; Mamman A; Banwat EB
    Niger J Med; 2008; 17(2):198-200. PubMed ID: 18686839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of demographic variables on cytomegalovirus antibody seropositivity among prospective blood donors in Jos, Nigeria.
    Alao OO; Mamman A; Araoye MO; Joseph E
    Niger Postgrad Med J; 2009 Jun; 16(2):139-42. PubMed ID: 19606194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi.
    Njeru DG; Mwanda WO; Kitonyi GW; Njagi EC
    East Afr Med J; 2009 Dec; 86(12 Suppl):S58-61. PubMed ID: 21591511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.
    Das B; Kaur G; Basu S
    Transfus Apher Sci; 2014 Jun; 50(3):438-42. PubMed ID: 24675015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Demographic Variables on Cytomegalovirus Antibody Seropositivity among Prospective Blood Donors in Jos, Nigeria.
    Oginni FO; Alao OO; Mamman A; Araoye MO; Joseph E
    Niger Postgrad Med J; 2009 Mar; 16(1):21-4. PubMed ID: 19305433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PREVALENCE AND ASSOCIATED CHARACTERISTICS OF CYTOMEGALOVIRUS (CMV) IMMUNOGLOBULIN ANTIBODIES AMONG BLOOD DONORS AT A UNIVERSITY TEACHING HOSPITAL IN NIGERIA.
    Bolarinwa RA; Donbraye E; Ademosu AA; Salawu L
    East Afr Med J; 2014 Nov; 91(11):385-90. PubMed ID: 26866086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
    Varga M; Görög D; Kári D; Környei E; Kis É; Túryné HJ; Jankovics I; Péter A; Toronyi É; Sárváry E; Fazakas J; Reusz G
    Transplant Proc; 2011 May; 43(4):1233-5. PubMed ID: 21620098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
    Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
    Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
    J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil.
    Souza MA; Passos AM; Treitinger A; Spada C
    Rev Soc Bras Med Trop; 2010; 43(4):359-61. PubMed ID: 20802930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and Seroconversion of Cytomegalovirus in a Large Group of Healthy, German Blood Donors: Potential Contribution to Transfusion Transmitted Infections.
    Kowalzik F; Hitzler W; Runkel S; Marron M
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood donor safety, prevalence and associated factors for cytomegalovirus infection among blood donors in Minna-Nigeria, 2014.
    Bawa MK; Mamman A; Olayinka A; Gidado S; Waziri NE; Balogun MS; Getso KI; Dalhat MM; Nsubuga P; Aliyu N; Bala H; Muhammad H; Haladu S; Shehu UL; Nguku PM
    Pan Afr Med J; 2019; 32(Suppl 1):6. PubMed ID: 30984327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
    Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
    Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of anti-CMV antibodies in blood donors in Ouagadougou (Burkina Faso)].
    Ouédraogo AS; Yaméogo JT; Poda GE; Kientega Y; Ouédraogo Traore R
    Med Sante Trop; 2012; 22(1):107-9. PubMed ID: 22871792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H; Qorashi M; Heidari A
    Transplant Proc; 2009 Sep; 41(7):2761-3. PubMed ID: 19765428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis.
    Adane T; Getawa S
    J Int Med Res; 2021 Aug; 49(8):3000605211034656. PubMed ID: 34382466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of cytomegalovirus antibodies in Thai blood donors.
    Kositanont U; Wasi C; Chandanayingyong D; Thongcharoen P
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):179-82. PubMed ID: 3000401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors.
    Furui Y; Satake M; Hoshi Y; Uchida S; Suzuki K; Tadokoro K
    Transfusion; 2013 Oct; 53(10):2190-7. PubMed ID: 23968359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of specific antibodies to cytomegalovirus in the blood donors in Qingdao].
    Zhao CQ; Shao JJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):78-81. PubMed ID: 2544278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of anti-CMV antibodies in blood donors in the Sfax region (value in blood transfusion)].
    Gargouri J; Elleuch H; Karray H; Rekik H; Hammami A
    Tunis Med; 2000; 78(8-9):512-7. PubMed ID: 11190729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.